Results 201 to 210 of about 38,715 (223)
Some of the next articles are maybe not open access.
The Journal of Pharmacology and Experimental Therapeutics, 1990
The effectiveness of presynaptic receptor agonists to inhibit the electrically evoked release of [3H]monoamines from brain slices is attenuated in the presence of blockade of neuronal uptake for the serotonin (5-HT) and the norepinephrine (NE) systems.
P, Blier, A M, Galzin, S Z, Langer
openaire +2 more sources
The effectiveness of presynaptic receptor agonists to inhibit the electrically evoked release of [3H]monoamines from brain slices is attenuated in the presence of blockade of neuronal uptake for the serotonin (5-HT) and the norepinephrine (NE) systems.
P, Blier, A M, Galzin, S Z, Langer
openaire +2 more sources
Psychopharmacology, 1993
Narcolepsy is currently treated with anti-depressants to control REM-related symptoms such as cataplexy and with amphetamine-like stimulants for the management of sleepiness. Both stimulant and antidepressant drugs presynaptically enhance monoaminergic transmission but both classes of compounds lack pharmacological specificity.
E, Mignot +5 more
openaire +2 more sources
Narcolepsy is currently treated with anti-depressants to control REM-related symptoms such as cataplexy and with amphetamine-like stimulants for the management of sleepiness. Both stimulant and antidepressant drugs presynaptically enhance monoaminergic transmission but both classes of compounds lack pharmacological specificity.
E, Mignot +5 more
openaire +2 more sources
Psychopharmacology, 1988
Fluoxetine, a novel antidepressant compound that potently and selectively inhibits serotonin uptake, was chronically administered to laboratory rats. Using in vitro receptor autoradiographic techniques, we found that the binding of [3H]-dihydroalprenolol [( 3H]-DHA) decreased significantly in frontal cortex layers.
W F, Byerley +5 more
openaire +2 more sources
Fluoxetine, a novel antidepressant compound that potently and selectively inhibits serotonin uptake, was chronically administered to laboratory rats. Using in vitro receptor autoradiographic techniques, we found that the binding of [3H]-dihydroalprenolol [( 3H]-DHA) decreased significantly in frontal cortex layers.
W F, Byerley +5 more
openaire +2 more sources
Brain Research, 1987
Sertraline, a potent and selective inhibitor of serotonin uptake, was chronically administered to laboratory rats. Using in vitro receptor autoradiographic techniques, we found that the binding of [3H]dihydroalprenolol ([3H]DHA) was reduced in cortex layers IV-VI.
W F, Byerley +5 more
openaire +2 more sources
Sertraline, a potent and selective inhibitor of serotonin uptake, was chronically administered to laboratory rats. Using in vitro receptor autoradiographic techniques, we found that the binding of [3H]dihydroalprenolol ([3H]DHA) was reduced in cortex layers IV-VI.
W F, Byerley +5 more
openaire +2 more sources
The Journal of Pharmacology and Experimental Therapeutics, 1970
R E, Maxwell +4 more
openaire +2 more sources
R E, Maxwell +4 more
openaire +2 more sources
Inhibitors of the Uptake of Norepinephrine by the Adrenergic Nerves in Rabbit Aorta
2015R. A. Maxwell +3 more
openaire +1 more source

